NASDAQ:ATRC

Atricure Stock News

Healthcare > Medical - Instruments & Supplies

Buy ATRC

*Your capital is at risk

$26.20

+0.340 (+1.31%)

At Close: Jun 03, 2026

AtriCure, Inc. (ATRC) Q2 2024 Earnings Call Transcript

12:01am, Wednesday, 31'st Jul 2024

AtriCure, Inc. (NASDAQ:ATRC ) Q2 2024 Earnings Conference Call July 30, 2024 4:30 PM ET Company Participants Marissa Bych - Investor Relations Michael Carrel - President and Chief Executive Officer An

AtriCure (ATRC) Reports Q2 Earnings: What Key Metrics Have to Say

06:31pm, Tuesday, 30'th Jul 2024

The headline numbers for AtriCure (ATRC) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimate

AtriCure (ATRC) Reports Q2 Loss, Lags Revenue Estimates

06:11pm, Tuesday, 30'th Jul 2024

AtriCure (ATRC) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.12 per share a year ago.

AtriCure to Participate in the Canaccord Genuity 44th Annual Global Growth Conference

08:00am, Monday, 29'th Jul 2024

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-o

AtriCure (ATRC) Gains China Approval for AtriClip LAA System

11:15am, Wednesday, 24'th Jul 2024

AtriCure (ATRC) receives NMPA approval to market AtriClip Left Atrial Appendage Exclusion System in China, marking a significant step in global expansion.

Have 20 Bucks? 7 Low-Priced Stocks That Could Double by 2025

06:50am, Friday, 28'th Jun 2024

Low-priced stocks to buy with the potential to double within the next year or so have inherent appeal for investors. Individual shares are affordable making it relatively easy to establish a stake.

AtriCure to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference

08:00am, Wednesday, 15'th May 2024

AtriCure, Inc. (ATRC) Q1 2024 Earnings Call Transcript

01:48am, Thursday, 02'nd May 2024

AtriCure, Inc. (NASDAQ:ATRC ) Q1 2024 Earnings Conference Call May 1, 2024 4:30 PM ET Company Participants Marissa Bych - Investor Relations Mike Carrel - President and Chief Executive Officer Angie W

Compared to Estimates, AtriCure (ATRC) Q1 Earnings: A Look at Key Metrics

09:00pm, Wednesday, 01'st May 2024

The headline numbers for AtriCure (ATRC) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimat

AtriCure (ATRC) Reports Q1 Loss, Tops Revenue Estimates

06:31pm, Wednesday, 01'st May 2024

AtriCure (ATRC) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.23 per share a year ago.